Sanofi (NASDAQ: SNY)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.920 | 1.090 | 0.1700 | ||||
REV | 10.030B | 10.859B | 829.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Sanofi (NASDAQ: SNY) through any online brokerage.
Other companies in Sanofi’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Sanofi (NASDAQ: SNY) was reported by SVB Leerink on Monday, September 27, 2021. The analyst firm set a price target for 0.00 expecting SNY to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Sanofi (NASDAQ: SNY) is $51.01 last updated July 1, 2022, 8:00 PM UTC.
A quarterly cash dividend of $1.17 per share of Class A Common Stock. The quarterly cash dividend was payable on June 4, 2018 to stockholders of record on May 9, 2018.
Sanofi’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Sanofi.
Sanofi is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.